Neoplasm AI
Scientific Software and Tumor Analysis for the AI Era
Cancer Analysis
At Neoplasm AI, we maximize the power of existing genomic assays. With our in-house models of tissue-type specific and cancer-stage specific somatic mutation, we move beyond mutation detection to characterize the specific biological processes occurring in the tumor.
By leveraging our StochasticParrots platform for AI-powered algorithm optimization, we turn general-purpose methods from the research lab into a broad array of highly specialized assays for clinical trial patient selection. In future, our growing arsenal of cancer tooling will be translated to clinical blood tests.
Algorithm Optimization
Inspired by systematic optimization processes from the electronics and aerospace industries (Axiomatic Design, TRIZ) we've broken down research commercialization into a repeatable and automation-friendly series of steps.
While scientific discovery is a remarkable human act, our AI-powered workflows can apply these discoveries where they are needed in an automated manner. We generate improvement patents, increase the speed and accuracy of existing hardware devices, and drop costs. We unlock highly specialized use-cases and help companies enter new markets.
Get in touch
Interested in working with us? Have a sensor, process, or 'omics' assay you are trying to improve?
Please reach out!
We are open to software partnerships with all hardware manufacturers, including startups with early-stage prototypes.